Processa Pharmaceuticals, Inc. Deferred Tax Assets, Other Tax Carryforwards
Processa Pharmaceuticals, Inc. (PCSA) had Deferred Tax Assets, Other Tax Carryforwards of $2.67 million as of 2018-12-31, per its 10-K/A filed 2019-04-08.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOtherTaxCarryforwards · last filed 2019-04-08
- 2018-12-31: Deferred Tax Assets, Other Tax Carryforwards $2.67M.
- 2017-12-31: Deferred Tax Assets, Other Tax Carryforwards $258.58K; Deferred Tax Assets, Other Tax Carryforwards as first filed $258.60K.
- 2016-12-31: Deferred Tax Assets, Other Tax Carryforwards $723.00.
- 2015-12-31: Deferred Tax Assets, Other Tax Carryforwards $1.52K.
| Period end | Deferred Tax Assets, Other Tax Carryforwards | Deferred Tax Assets, Other Tax Carryforwards as first filed |
|---|---|---|
| 2018-12-31 | $2.67M 10-K/A · filed 2019-04-08 | |
| 2017-12-31 | $258.58K 10-K/A · filed 2019-04-08 | $258.60K 10-K · filed 2018-04-16 |
| 2016-12-31 | $723.00 10-K · filed 2017-09-25 | |
| 2015-12-31 | $1.52K 10-K · filed 2017-09-25 | |
| 2014-12-31 | $15.14K 10-K · filed 2017-06-19 | |
| 2013-12-31 | $7.71K 10-K · filed 2015-04-14 | |
| 2012-12-31 | $7.46K 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |